Who invested in LTZ Therapeutics?
LTZ Therapeutics's investors include Qiming Venture Partners, Shunwei Capital, Eli Lilly, 5Y Capital and GL Ventures, and 1 more on record. GL Ventures led its latest round.

United States · Venture startup
2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 6 months ago
Follow LTZ Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$38Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by Ventureburn
Source recorded
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
LTZ Therapeutics's investors include Qiming Venture Partners, Shunwei Capital, Eli Lilly, 5Y Capital and GL Ventures, and 1 more on record. GL Ventures led its latest round.
LTZ Therapeutics has raised $38M across 2 rounds since 2025. One round did not disclose an amount, so the total is a floor.
LTZ Therapeutics's most recent round, $38M, was in May 2026, led by GL Ventures.
Its most recent round, $38M in May 2026, is also its largest on record.
LTZ Therapeutics's first round on record, in Jul 2025, was backed by Qiming Venture Partners, Shunwei Capital and K2VC and 2 others.
LTZ Therapeutics's latest named round is a Venture, in Jul 2025.
LTZ Therapeutics is based in the United States.
GL Ventures led the funding round in 2026.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.